Skip to main content
. 2023 May 5;2023(5):CD006103. doi: 10.1002/14651858.CD006103.pub8

NCT01800019.

Study name The Canadian HIV Quit Smoking Trial: tackling the co‐morbidities of depression and cardiovascular disease in HIV+ smokers (CANQUIT)
Methods Open‐label, 4‐arm, factorial RCT
Participants 256 adults who are HIV+ and smoke, 5+ CPD, willing to set a quit date
Interventions
  • NRT

  • NRT + HIV‐tailored quit smoking counselling

  • Varenicline

  • Varenicline + HIV‐tailored quit smoking counselling

Outcomes 7‐day PPA and 4‐week CA at week 48, CO‐verified
Starting date January 2014
Contact information Louise Balfour, PhD, Ottawa Hospital Research Institute
Notes Study funding: CIHR Research Operating Grant